start portlet menu bar

Просмотр веб-материалов

Display portlet menu
end portlet menu bar

Clinical protection study of pseudorabies vaccine (AUSKIPRA® GN bartha k61 strain) in piglets infected with new Chinese PRV variant

Домашняя страница Знания Clinical protection study of pseudorabies vaccine (AUSKIPRA® GN bartha k61 strain) in piglets infected with new Chinese PRV variant

Clinical protection study of pseudorabies vaccine (AUSKIPRA® GN bartha k61 strain) in piglets infected with new Chinese PRV variant

Since 2011, several pseudorabies (PR) outbreaks have damaged Chinese swine industry. The purpose of this experiment is to test the efficacy of pseudorabies vaccine AUSKIPRA® GN (HIPRA) against new pseudorabies virus variant (AH02).

Скачать эту статью

816 КБ

Об этой статье

Опубликовано в

APVS Congress, 2015

Авторы

Zeng, R.; Wang, J.; Torrents, D.; Martinez, C.; Pedrazuela, R.; Galé, I.

Общий обзор

In this study AUSKIPRA® GN reconstituted with RED solvent reduce mortality, lung lesions and fever. Therefore, AUSKIPRA® GN can provide clinical protection in front of new PRV strains.

Похожие услуги

Диагностические услуги

Похожие продукты

AUSKIPRA® GN

Похожие публикации

Survey of pseudorabies sero-prevalence in 11 provinces of China Retrospective study on the prevalence of Aujeszky's disease in major pig producing provinces in the Philippines (2006-2010) Pseudorabies (Aujeszky’s virus disease) vaccination protocols in China

Поделиться

start portlet menu bar

Clinical protection study of pseudorabies vaccine (AUSKIPRA® GN bartha k61 strain) in piglets infected with new Chinese PRV variant

Display portlet menu
end portlet menu bar

Смотрите также

Публикации

Intradermal vaccination with UNISTRAIN® PRRS in gilts improves the performance of their of...

30-07-2018
Резюме болезней

Edema disease

03-11-2017
Новости

HIPRA participates in the 52nd AMVEC Congress, 2018

14-09-2018